CA
NZ
UK
AU
IND
US
• The incoming director brings extensive experience in healthcare leadership and corporate governance.
• MoonLake Immunotherapeutics (NASDAQ: MLTX) has initiated a $200 million equity and warrant sale to bolster its financial resources.
• PAVmed Inc. (NASDAQ: PAVM) filed an 8-K with the SEC detailing amendments to its employee stock purchase plan (ESPP).
• SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) updates executive severance terms, including a one-half (1.5) times payment for the year in which employment terminates.
• Carolyn Starrett joins Neogenomics Inc (NASDAQ: NEO) Board of Directors with over two decades of experience in healthcare leadership and commercial strategy.
• Underwriters received a 30‑day option to buy up to 741,758 additional shares.
• Absci Corporation (NASDAQ: ABSI) priced a $100 million underwritten equity offering at $7.41 per share.
• The company amended its bylaws on June 24, 2026, introducing stricter protocols for stockholder meetings and voting rights.
• CUPR closed near $5.74 on June 24, 2026, surging nearly 46% on elevated volume in a very thin-float name.
• CRL closed at $202.10 on June 24, 2026, gaining more than 8% in a broad CRO sector recovery session.
Please wait processing your request...